lamotrigine
CHEBI:CHEBI_6367
Definition
A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6.
Chemical Information
- Molecular Formula
- C9H7Cl2N5
- Molecular Mass
- 256.09100
- Charge
- 0
- SMILES
- Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl
- InChI
- InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
- InChIKey
- PYZRQGJRPPTADH-UHFFFAOYSA-N
Alternative Names
- 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
- 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
- Lamictal
- lamotrigina
- lamotrigine
- lamotriginum
Drug Classification
-
dichlorobenzeneView Class →
CHEBI:23697
-
DichlorobenzeneView Class →
CHEBI:23697
-
primary arylamineView Class →
CHEBI:50471
-
1,2,4-triazinesView Class →
CHEBI:39410
-
t261748
-
t261766
-
t261951
-
t262191
-
t262222
-
t262284
-
t262305
-
t262382
-
t262424
-
t262596
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Wikipedia:Lamotrigine
- DRON_00010000
- 28439
- core#notation
- CHEBI:6367
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- marketing_start_date
- 20001012
- labeler_name
- Suven Pharmaceuticals Limited
- dosage_form
- TABLET, FOR SUSPENSION
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- application_number
- ANDA078009
- product_ndc
- 68071-2960
- route
- ORAL
- package_ndc
- 50090-2129-1
- spl_id
- 976bb1e6-e2b0-4900-9ca9-83eac46ed984
- package_description
- 100 TABLET in 1 BOTTLE (65841-684-01)
- listing_expiration_date
- 20241231
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Lamotrigine
- DRON_00010000
- 28439
- oboInOwl#id
- CHEBI:6367
- generic_name
- Lamotrigine ER
- brand_name
- Lamotrigine ER
- brand_name_base
- Lamotrigine ER
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_60798
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- package_marketing_start_date
- 25-SEP-09
- manufacturer_name
- Camber Pharmaceuticals Inc
- active_ingredient_name
- LAMOTRIGINE
- active_ingredient_strength
- 75 kg/75kg
- spl_set_id
- 4b72ea7a-a0b0-4980-84ad-84f64e2e6368
- nui
- N0000000191
- upc
- 0382804068302
- core#notation
- CHEBI:6367
- pharm_class_epc
- Mood Stabilizer [EPC]
- pharm_class
- Dihydrofolate Reductase Inhibitors [MoA]
- pharm_class_pe
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- pharm_class_moa
- Dihydrofolate Reductase Inhibitors [MoA]
- brand_name_suffix
- Kit
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rxcui
- 2003801
- unii
- U3H27498KS
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0080457
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30832
- owl#annotatedSource
- t262972
- owl#someValuesFrom
- t2909592